Discovery of BMS-986251: A Clinically Viable, Potent, and Selective RORγt Inverse Agonist.

Publication

Citation
Cherney RJ, Cornelius LAM, Srivastava A, Weigelt CA, Marcoux D, Duan JJ, Shi Q, Batt DG, Liu Q, Yip S, Wu DR, Ruzanov M, Sack J, Khan J, Wang J, Yarde M, Cvijic ME, Mathur A, Li S, Shuster D, Khandelwal P, Borowski V, Xie J, Obermeier M, Fura A, Stefanski K, Cornelius G, Tino JA, Macor JE, Salter-Cid L, Denton R, Zhao Q, Carter PH, Dhar TGM.: Discovery of BMS-986251: A Clinically Viable, Potent, and Selective RORγt Inverse Agonist. ACS Med Chem Lett, Volume 11 (6), 2020
Authors
Batt DG, Borowski V, Carter PH, Cherney RJ, Cornelius G, Cornelius LAM, Cvijic ME, Denton R, Dhar TGM., Duan JJ, Fura A, Khan J, Khandelwal P, Li S, Liu Q, Macor JE, Marcoux D, Mathur A, Obermeier M, Ruzanov M, Sack J, Salter-Cid L, Shi Q, Shuster D, Srivastava A, Stefanski K, Tino JA, Wang J, Weigelt CA, Wu DR, Xie J, Yarde M, Yip S, Zhao Q
Journal
ACS Med Chem Lett
Year
2020
PubMed
32551004
Machine-readable
REST APIRDF
Palacky University Olomouc

Palacky University Olomouc

Faculty of Science

Department of Physical Chemistry

tř. 17. listopadu 1192/12

771 46 Olomouc

Czech Republic

How to cite?

Juračka J., Šrejber M., Melíková M., Bazgier V., Berka K.: MolMeDB: Molecules on Membranes Database. Database, Volume 2019, 2019, baz078, https://doi.org/10.1093/database/baz078

Follow us

FacebookGithub

Financial Support

  • MolMeDB interoperability with UniProt and SwissLipids – MEYS Czech-Swiss project ELIXIR-IMPACT 8K0208 (2026–2028)
ELIXIRGAČRUP Olomouc